+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Short Bowel Syndrome Market - Global Forecast 2026-2032- Product Image
Short Bowel Syndrome Market - Global Forecast 2026-2032- Product Image
New

Short Bowel Syndrome Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011692
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The short bowel syndrome market is advancing, shaped by clinical research, the evolution of care models, and a focus on integrated, patient-centered approaches. Senior decision-makers are navigating new pressures that require targeted strategies and up-to-date market intelligence for sustainable success.

Market Snapshot: Short Bowel Syndrome Market Size and Growth

The short bowel syndrome market is set for substantial growth, expanding from USD 1.22 billion in 2025 to USD 1.32 billion in 2026, at a compound annual growth rate (CAGR) of 9.50% and expected to reach USD 2.31 billion by 2032. This progression reflects heightened clinical requirements, notable therapeutic advancements, and a broader move toward integrated care for medically complex populations.

Scope & Segmentation: Short Bowel Syndrome Market

  • Treatment Types: Includes oral supplementation such as dietary supplements and nutritional formulas, parenteral nutrition encompassing both customized and standard PN, pharmacological therapies like antibiotics, growth factors, and hormonal agents, in addition to surgical procedures involving lengthening or transplantation.
  • Product Classes: Involves adjunctive therapies, including probiotics, vitamins, and minerals, as well as enteral formulas (elemental, polymeric, semi-elemental), pharmacological products (notably teduglutide), and parenteral nutrition solutions (amino acid, carbohydrate, and lipid-based solutions).
  • Administration Routes: Covers both intravenous and oral options, influencing patient adherence, complexity of ongoing monitoring, and investments in decentralized or home-based care.
  • Care Settings: Spans home care, hospitals, and specialty clinics, each with distinct procurement pathways, reimbursement strategies, and partnership models.
  • Patient Groups: Addresses the specific nutritional, risk, and dosing needs of pediatric, adult, and geriatric populations.
  • Etiologies: Encompasses congenital origins, Crohn disease, and mesenteric ischemia, each driving differences in disease development and treatment pathways.
  • Regions: Includes the Americas, Europe/Middle East/Africa, and Asia-Pacific, each characterized by regulatory variations, supply chain infrastructure, and local market maturity.
  • Technologies: Features advances such as remote patient monitoring, the adoption of real-world data registries, and improvements in the formulation of enteral and parenteral products.

Key Takeaways for Senior Decision-Makers

  • Increasing clinical complexity is encouraging greater reliance on multidisciplinary care models integrating hospital, clinic, and home health environments.
  • New pharmacologic and nutrition technologies are providing alternatives to complete parenteral nutrition, supporting transitions toward oral or mixed modality regimens.
  • Digital health tools, including telemonitoring solutions, facilitate earlier identification of complications and boost the reliability of home-based treatment continuity.
  • Economic modeling and real-world evidence are playing a larger role in payer engagement, emphasizing the importance of robust data collection and outcomes tracking through registries.
  • Segment-specific messaging and bundled care programs support clinical and commercial differentiation across age groups and etiologies, enhancing adoption.
  • Regional regulatory nuances and tailored distribution approaches are becoming more vital for achieving efficient market access and sustained patient reach.

Tariff Impact: Navigating Trade and Supply Chain Shifts

Recent U.S. tariff initiatives are prompting suppliers and manufacturers to reassess their sourcing strategies, particularly for critical nutritional ingredients and device components. These measures are contributing to higher procurement costs and are encouraging a more diversified supplier base, near-shoring options, and increased inventory reserves. For providers and payers, transparent communication around value and cost management is essential as market pricing and procurement strategies adapt to these ongoing supply chain shifts.

Methodology & Data Sources

This report employs a mixed-method framework, leveraging in-depth reviews of clinical publications, regulatory documentation, expert interviews, and operational records. Scenario analysis, coding of qualitative themes, and detailed segmentation form the basis of aligning product developments with end-user requirements. Scope limitations apply to country-level details and fast-changing policy landscapes.

Why This Report Matters

  • Supports senior leadership with actionable, region-specific insights that drive informed investment and operational decisions.
  • Facilitates early detection of supply chain or regulatory changes, reducing business risk associated with tariff impacts and care delivery evolution.
  • Prepares organizations to strengthen payer relationships, refine market-entry tactics, and fortify against disruptions in access or reimbursement.

Conclusion

Advancements in clinical care, operational excellence, and payer engagement are combining to reshape the short bowel syndrome landscape. Aligning innovation with strategy ensures patient access remains central as market demands and regulatory frameworks evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Short Bowel Syndrome Market, by Treatment Type
8.1. Oral Supplementation
8.1.1. Dietary Supplements
8.1.2. Nutritional Formulas
8.2. Parenteral Nutrition
8.2.1. Customized Pn
8.2.2. Standard Pn
8.3. Pharmacological Therapy
8.3.1. Antibiotics
8.3.2. Growth Factors
8.3.3. Hormonal Agents
8.4. Surgical Intervention
8.4.1. Bowel Transplantation
8.4.2. Intestinal Lengthening Procedures
9. Short Bowel Syndrome Market, by Product Type
9.1. Adjunctive Therapies
9.1.1. Probiotics
9.1.2. Vitamins And Minerals
9.2. Enteral Formulas
9.2.1. Elemental Formulas
9.2.2. Polymeric Formulas
9.2.3. Semi-elemental Formulas
9.3. Pharmacologics
9.3.1. Teduglutide
9.4. Pn Solutions
9.4.1. Amino Acid Solutions
9.4.2. Carbohydrate Solutions
9.4.3. Lipid Emulsions
10. Short Bowel Syndrome Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
11. Short Bowel Syndrome Market, by Patient Age
11.1. Adult
11.2. Geriatric
11.3. Pediatric
12. Short Bowel Syndrome Market, by Etiology
12.1. Congenital Conditions
12.2. Crohn Disease
12.3. Mesenteric Ischemia
13. Short Bowel Syndrome Market, by End Use
13.1. Home Care Facilities
13.2. Hospitals
13.3. Specialty Clinics
14. Short Bowel Syndrome Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Short Bowel Syndrome Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Short Bowel Syndrome Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Short Bowel Syndrome Market
18. China Short Bowel Syndrome Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Ajinomoto Co., Inc.
19.6. Becton, Dickinson and Company
19.7. CordenPharma International AG
19.8. Gland Pharma Limited
19.9. Hikma Pharmaceuticals PLC
19.10. ICU Medical, Inc.
19.11. Lonza Group AG
19.12. Otsuka Holdings Co., Ltd.
19.13. Smiths Medical (Smiths Group plc)
19.14. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SHORT BOWEL SYNDROME MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SHORT BOWEL SYNDROME MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA SHORT BOWEL SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY NUTRITIONAL FORMULAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY NUTRITIONAL FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY NUTRITIONAL FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CUSTOMIZED PN, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CUSTOMIZED PN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CUSTOMIZED PN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY STANDARD PN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY STANDARD PN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY STANDARD PN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HORMONAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HORMONAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY BOWEL TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY BOWEL TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY BOWEL TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTESTINAL LENGTHENING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTESTINAL LENGTHENING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTESTINAL LENGTHENING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY VITAMINS AND MINERALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY VITAMINS AND MINERALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY VITAMINS AND MINERALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ELEMENTAL FORMULAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ELEMENTAL FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ELEMENTAL FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY POLYMERIC FORMULAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY POLYMERIC FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY POLYMERIC FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SEMI-ELEMENTAL FORMULAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SEMI-ELEMENTAL FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SEMI-ELEMENTAL FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TEDUGLUTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TEDUGLUTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY TEDUGLUTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY AMINO ACID SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY AMINO ACID SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY AMINO ACID SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CARBOHYDRATE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CARBOHYDRATE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CARBOHYDRATE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY LIPID EMULSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY LIPID EMULSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY LIPID EMULSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CONGENITAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CONGENITAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CROHN DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CROHN DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY CROHN DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY MESENTERIC ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY MESENTERIC ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY MESENTERIC ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOME CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOME CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 188. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 196. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 218. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 221. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 222. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 223. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 224. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 226. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 228. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 229. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 231. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 252. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 253. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 254. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 255. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 257. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 259. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 260. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 262. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 263. ASEAN SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 264. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 266. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 267. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 268. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 269. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 270. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 272. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 273. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 274. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 275. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 277. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 278. GCC SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 294. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 296. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 297. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 298. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 299. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 300. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 302. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 303. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 304. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 305. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 306. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 307. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY ETIOLOGY, 2018-2032 (USD MILLION)
TABLE 308. BRICS SHORT BOWEL SYNDROME MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 309. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 311. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY ORAL SUPPLEMENTATION, 2018-2032 (USD MILLION)
TABLE 312. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 313. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 314. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 315. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 316. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 317. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY ENTERAL FORMULAS, 2018-2032 (USD MILLION)
TABLE 318. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY PHARMACOLOGICS, 2018-2032 (USD MILLION)
TABLE 319. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY PN SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 320. G7 SHORT BOWEL SYNDROME MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 321. G7 SHORT BOWEL SYNDROME MA

Companies Mentioned

The key companies profiled in this Short Bowel Syndrome market report include:
  • Ajinomoto Co., Inc.
  • Becton, Dickinson and Company
  • CordenPharma International AG
  • Gland Pharma Limited
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • Lonza Group AG
  • Otsuka Holdings Co., Ltd.
  • Smiths Medical (Smiths Group plc)
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.32 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.31 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Short Bowel Syndrome (SBS) - Global Strategic Business Report - Product Image

Short Bowel Syndrome (SBS) - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Short Bowel Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Short Bowel Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Short Bowel Syndrome Drug Pipeline Analysis Report 2025 - Product Image

Short Bowel Syndrome Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Short Bowel Syndrome - Pipeline Insight, 2025 - Product Image

Short Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Irritable Bowel Syndrome (Ibs) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Irritable Bowel Syndrome (Ibs) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Short Bowel Syndrome Drug Market

Short Bowel Syndrome (SBS) is a rare disorder that affects the small intestine, resulting in malabsorption of nutrients and fluids. It is typically caused by the surgical removal of a large portion of the small intestine, or by a congenital defect. Treatment for SBS typically involves the use of specialized drugs to help the body absorb nutrients and fluids, as well as to reduce the risk of infection. The SBS drug market is a subset of the larger gastrointestinal drug market, which includes drugs used to treat a variety of gastrointestinal disorders. The SBS drug market is relatively small, but is expected to grow in the coming years due to increasing awareness of the disorder and the development of new treatments. Some of the major companies in the SBS drug market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.